Compare Medpace Holdings Inc (MEDP) vs Prudential Financial Inc (PRU) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Medpace Holdings Inc vs Prudential Financial Inc — how do they compare? Medpace Holdings Inc trades at $519.93 (market cap $15.08B), while Prudential Financial Inc trades at $117.15 (market cap $40.97B). The key difference: Prudential Financial Inc is far larger — about 2.7× Medpace Holdings Inc's market cap, and Prudential Financial Inc pays a 4.75% dividend while Medpace Holdings Inc pays none. Which is the better fit depends on your goals.
| MEDP | PRU | |
|---|---|---|
Market Cap | $15.08B | $40.97B |
Sector | Technology | Financials |
52-Week High | $620.59 | $119.07 |
52-Week Low | $308.88 | $92.00 |
Enterprise Value | $14.55B | $68.03B |
Dividend Yield | — | 4.75% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
MEDP trades at $527.93, down 1.82% today, with a bullish technical outlook supported by moving averages. The company demonstrates strong profitability with 17.19% net margins and 77.25% ROE, though valuation ratios appear elevated with a P/E of 33.83. Recent earnings have consistently beaten expectations, and cash flow is projected to improve significantly in 2026. However, the stock faces headwinds from ongoing class action lawsuits and mixed analyst sentiment with 73.69% hold ratings.
MEDP presents a mixed investment case with strong fundamental performance offset by legal overhangs and premium valuation. The company's consistent earnings beats and projected cash flow improvement support upside potential, but investors should weigh the legal risks and cautious analyst stance against the robust operational metrics.
Prudential Financial (PRU) trades at $118.04, down 0.87% on the day, showing mixed technical signals with a bullish overall trend but overbought RSI indicators. Fundamentally, the company demonstrates solid profitability with 5.5% net income margin and 11.08% ROE, though revenue declined from $70.7B in 2024 to $61.0B in 2025. Recent earnings show beats in Q3 2025 and Q1 2026, with Q2 2026 results expected August 4, 2026.
The stock presents a value opportunity with attractive valuation multiples (P/E 12.26, P/S 0.67) but faces headwinds from analyst skepticism (67.57% hold rating) and a consensus price target of $102.50 below current levels. Key risks include revenue volatility and high debt levels, while catalysts include retirement market growth and international expansion driving long-term earnings potential.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Medpace Holdings Inc
Medpace Holdings, Inc. is a full-service clinical contract research organization (CRO) that provides comprehensive and scientifically-driven clinical development services to the biotechnology, pharmaceutical, and medical device industries. The company specializes in conducting global clinical trials for new drug and medical device approvals. Medpace's model emphasizes therapeutic expertise and a highly integrated approach to accelerate the clinical development process for its clients.
Read more on MEDP →About Prudential Financial Inc
Prudential Financial is a large, diversified insurance company offering annuities, life insurance, retirement plan services, and asset management products. While it operates in a number of countries, the vast majority of revenue is generated in the United States and Japan. The company's investment management business, PGIM, contributes approximately 15% of its earnings and has over $1.5 trillion in assets under management. The U.S. businesses are responsible for about 45% of earnings and can be classified into Institutional Retirement Strategies, Individual Retirement Strategies, Group Insurance, Individual Life Insurance, and Assurance IQ. Finally, the international business segment of the company contributes approximately 40% of earnings with a strong market position in Japan.
Read more on PRU →
